Saturday, April 23, 2011

Rx for Secondary Prevention May Not Save Money

There is a lack of evidence that drugs such as statins and anti-hypertensives used to reduce risk of cardiovascular events are cost-effective treatments, according to a study from Finland published online in the BMJ.


No comments:

Post a Comment